1. Home
  2. BGC vs SRRK Comparison

BGC vs SRRK Comparison

Compare BGC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGC Group Inc.

BGC

BGC Group Inc.

HOLD

Current Price

$9.46

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$47.76

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGC
SRRK
Founded
1945
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.6B
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
BGC
SRRK
Price
$9.46
$47.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$14.50
$51.20
AVG Volume (30 Days)
2.1M
1.0M
Earning Date
02-12-2026
02-26-2026
Dividend Yield
0.89%
N/A
EPS Growth
36.46
N/A
EPS
0.33
N/A
Revenue
$2,640,884,000.00
N/A
Revenue This Year
$36.53
N/A
Revenue Next Year
$11.33
$20,029.43
P/E Ratio
$27.14
N/A
Revenue Growth
24.59
N/A
52 Week Low
$7.24
$22.71
52 Week High
$10.96
$49.82

Technical Indicators

Market Signals
Indicator
BGC
SRRK
Relative Strength Index (RSI) 61.25 57.31
Support Level $8.81 $44.10
Resistance Level $9.18 $48.00
Average True Range (ATR) 0.29 2.39
MACD 0.02 0.15
Stochastic Oscillator 88.89 69.64

Price Performance

Historical Comparison
BGC
SRRK

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: